According to the phosphoproteomics data, we identify the CD44-Stat3 axis, the phosphorylation of which is impeded toward afatinib and IR treatment, might play a pivotal role in afatinib enhancing radiosensitivity in NPC cells. Here, CD44 is linked to nasopharyngeal carcinoma.